Dr. Reddy’s Laboratories has launched the first generic version of Vimovo tablets, used to treat rheumatoid arthritis, in the US market. The company announced the first-to-market launch of Naproxen and Esomeprazole Magnesium delayed-release tablets in the US market.
The company's product is the generic version of Vimovo tablets approved by the US Food and Drug Administration (USFDA).
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
